Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Emerging Biopharma
Biotech
Medera plans SPAC merger to advance cardiac gene therapies
The SPAC is bringing around $149.5 million to the party, which will contribute to the combined company’s implied initial value of $622.6 million.
James Waldron
Sep 5, 2024 10:50am
Lilly, Haya ink $1B biobuck obesity pact to search dark genome
Sep 4, 2024 8:00am
Duality seeks cash for ADC trials as IPO wave spreads to Asia
Aug 27, 2024 9:20am
MBX files for IPO to take challenger to Ascendis into phase 3
Aug 26, 2024 9:40am
Bicara, Zenas seek IPOs to push late-phase assets toward market
Aug 23, 2024 5:07am
A VC recovery may be coming in Europe: PitchBook
Aug 22, 2024 3:00pm
More News
Lilly taps Oblique for new angle on high-value antibody target
Aug 22, 2024 9:13am
Novartis, Versant hope to repeat Chinook’s success with Borealis
Aug 22, 2024 8:00am
Catalyze360 aims to expand beyond Lilly's core drug ethos
Aug 19, 2024 9:43am
Metagenomi axes ALS program after seeing Biogen and Ionis flop
Aug 14, 2024 9:20am
See more stories